Article: Listed Futures as Alternative to OTC Swaps22 November 2016 | Steven Griffiths
Over the past year, I’ve been speaking to buy-side UK and European clients and discussing issues they might not be aware of yet instead of challenges they are currently facing, with the aim to bring best practises from a variety of sources on the latest developments to incorporate in their business and add value; whether it’s trading practises, collateral optimisation or pre-trade total cost analysis (TCA).
At first, I was interested in understanding which clients were Category 2 and 3 across Europe as I wanted to discuss their readiness to clear. I found a number of interesting outcomes, and for me, the most interesting were some clients actively reducing their OTC Swap exposure to below category 2 thresholds so the company / fund didn't have to comply with EMIR by 21st December 2017.
This was to allow time for looking at alternative products as a suitable hedge - as their finding showed the costs involved in trading OTC Swaps would create a drag on their